Featured on Forbes: The synthetic biology companies racing to fight the coronavirus

AbCellera has been listed alongside a suite of other biotechnology companies, including Moderna, GenScript, and Mammoth Biosciences, that are actively responding to COVID-19. Under the DARPA Pandemic Prevention Platform (P3) program, AbCellera is working to rapidly identify antibodies that can neutralize the virus and potentially block its transmission.

 

Read full coverage on Forbes.

PARTNERSHIP

Together we can make game-changing discoveries.